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NMDA receptors: do glia hold the key?
NMDA receptor stimulation requires binding of a 'co-agonist' and the
neurotransmitter glutamate at separate sites. Are ligands for the co-agonist
site liberated by glia, following activation of glial glutamate receptors?
The NMDA (N-methyl-D-aspartate) type of glutamate
receptor appears unique among mammalian synaptic
receptors in requiring the binding of a co-agonist,
namely glycine, for its activation. NMDA receptor-chan-
nels are also sensitive to low concentrations of Mg2 +,
Zn2+, polyamines and protons - all of which occur in
the normal extracellular milieu and modify the receptors'
properties (see [1]). Furthermore, some of these mol-
ecules (such as Mg2+; see [2]) bind to more than one site
on the receptor-channel, giving rise to diverse effects.
Elucidating the roles played by these binding sites on the
receptor is crucial to our understanding of the various
processes carried out by NMDA receptors. The role of
Mg2 + appears well-understood - it confers a voltage-
dependent block on the channel, which is relieved as the
cell is depolarized [3]. This allows the NMDA receptor
to function as an activity sensor, permitting an influx of
Ca2 + and Na+ ions only in those cells that receive high-
frequency synaptic inputs (the synaptic current near resting
potential being carried mainly by non-NMDA receptors).
On the other hand, the role of the glycine site on the
receptor is far from clear. Glycine binding appears to be an
absolute requirement for NMDA receptor activation [4].
What advantages are gained by requiring glutamate to act
in concert with glycine as a co-agonist? This question is
especially perplexing given that glycine can be detected
in the cerebrospinal fluid in the micromolar concentra-
tion range, whereas the concentration at which glycine is
half-maximally effective on the receptor (the EC 50) may
be as low as - 150 nM (see [1]) - implying that the
glycine-binding site on the receptor is saturated under
normal conditions. This problem aside, the requirement
for glycine is of considerable pharmacological and thera-
peutic interest, as antagonism of the glycine-binding site
is an alternative strategy for blocking NMDA.receptor
activity, without acting on the glutamate recognition site
(see [5]). This is of obvious importance in some patholog-
ical conditions, as the rise in intracellular Ca2 + associated
with prolonged NMDA receptor activation can prove
fatal to neurons; indeed this appears to be a major cause
of the cell death associated with stroke and ischaemia.
For the action of glycine on NMDA receptors to take on
a clear physiological significance, the concentration of
glycine present at the synapse must normally be kept
below saturating levels. Does this happen? Although this is
a difficult question to answer unequivocally, there is indir-
ect evidence to suggest that it might. In situ hybridization
data have shown that at least one glycine transporter has a
distribution which closely follows that of NMDA recep-
tors in the central nervous system [6], consistent with the
idea that the glycine concentration at glutamate synapses
may be regulated by glycine uptake. Moreover, ex-
ogenous glycine can enhance the NMDA component of
the synaptic current at some synapses, as measured in brain
slices [7]. Despite this suggestive evidence, a general role
for glycine modulation in vivo remains to be established.
Glial cells provide one possible source of glycine. Certain
glial cells have fast glutamate receptor-channels (see
[8-10]), activation of which can provoke the release of
glycine and other amino acids [11]. These glutamate
receptors are of the non-NMDA type and occur in cul-
tured cells of the oligodendrocyte/type-2 astrocyte lin-
eage - namely, O-2A progenitor cells, type- 2 astrocytes
[10,12] and oligodendrocytes [13] - but not in type-1-
like astrocytes [12]. Furthermore, they are also present in
the cerebellar radial glial cells - the Bergmann glia [14]
- and in a subpopulation of glial cells in vivo [15]. As
illustrated in Figure 1, cells that have glutamate receptors
have been directly visualized in the intact white matter of
both developing and adult rat optic nerve. These have
been identified following activation of non-NMDA
receptors in the presence of cobalt, which then enters the
cells via glutamate receptor-channels [15]. As the optic
nerve lacks neuronal cell bodies, the labeled cells must be
glia. All the evidence points to these cells being O-2A
progenitors and not astrocytes.
The role of these glial glutamate receptors has remained a
puzzle, especially as there are several functionally distinct
subtypes, including AMPA (ot-amino-3-hydroxy-5
methyl-4-isoxazole propionic acid) [10,16] and kainate
receptors [13]. Furthermore, the AMPA receptors in
Bergmann glia are exclusively of the Ca2 +-permeable
variety, as these cells lack the Ca2 +-impermeable GluR-2
receptor subunit [14]. Glutamate receptor-channels in
O-2A-lineage cells have been suggested to play a role in
neuronal-glial signaling, and to be activated by neurally
released transmitter. It is not known, however, whether
glial receptors are located near sites where they will be
exposed to transmitter (see [10,12,17]).
Various studies provide a potential mechanism for amino-
acid release from astrocytes and O-2A progenitors. It is
clear that a large number of amino acids and neuro-
transmitters (including GABA (y-aminobutyric acid),
glutamate, aspartate, glycine, taurine, alanine and serine)
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Fig. 1. Cobalt-filled cells in rat optic nerve following exposure of intact nerves to 100 p.M quisqualate (an AMPA receptor agonist) in the
presence of 5 mM cobalt. Intracellular cobalt was visualized by precipitation with ammonium sulphide followed by silver intensifica-
tion. (a) Developing (23-day-old) rat optic nerve; 20 tLm sections counterstained with Borrel's methylene blue. The cell bodies of cobalt-
filled cells are located in the columns of glial cells. Their long fine processes lie in close proximity to other glial cells and also ramify
through the axon bundles. (b) Adult rat optic nerve whole-mount. Cobalt-filled cells are at lower density than in developing nerves, but
their processes form an extensive network. Bar = 100 m in (a), 200 pLm in (b). Photographs kindly provided by Barbara Fulton.
are released from cultured type-2 astrocytes following stim-
ulation of their glutamate receptors [11,18]. In the case of
GABA release, this appears to be due to 'reversed uptake'
of the transmitter [18], a mechanism originally described
to explain the Ca2 +-independent release of neurotrans-
mitter from horizontal cells in the retina [19]. According
to this proposed mechanism, a rise in intracellular Na+
concentration, or simple membrane depolarization, is
expected to reverse the normal Na+-dependent uptake
mechanism for amino acids such as GABA and glutamate
[19,20]. Given that O-2A-lineage cells have an apprecia-
ble density of glutamate receptors, activation of which
will depolarize the cells [12,13] and raise intracellular
Na+ [21], reversal of uptake following receptor activation
could afford a mechanism for releasing amino acids that
may modulate NMDA receptors [11]. Attwell et al. [22]
have suggested that neurotransmitter glutamate, released
from nerve terminals, might activate non-NMDA recep-
tors in glial cell processes, to allow the release of glycine
which then acts at the NMDA receptor glycine site.
A recent study suggests a new twist to some of these
observations. Schell et al. [23] report that there are high
levels of the amino acid D-serine in process-bearing glial
cells in neuropil, and in type-2 astrocytes in tissue cul-
ture. They also find that, in some regions of the central
nervous system, the distribution of D-serine coincides
well with that of NMDA receptors. In culture, D-serine is
liberated from type-2 astrocytes if they are stimulated by
glutamate. It has been known for some time that D-serine
can mimic the effects of glycine on NMDA receptors (see
[5]). Schell et al. [23] therefore propose a scheme similar
to that of Attwell and colleagues [22], but with D-serine,
rather than glycine, acting as the natural co-agonist for
the 'glycine site' of the NMDA receptor. This proposi-
tion comes as a surprise, not least because D-isomers of
amino acids are relatively rare in vertebrate systems.
Despite the suggestive results provided by these various
studies, it is too early to say whether astrocyte-derived
amino acids are involved in modulating NMDA receptors
in vivo. A number of questions remain. First, are astro-
cytes the strongest candidates for providing the source of
D-serine in vivo? Although it is clear that type-2 astro-
cytes in culture contain D-serine, and they release it fol-
lowing glutamate receptor activation, mounting evidence
suggests that this cell type may not normally occur in
vivo, but may be generated only in pathological condi-
tions and in vitro (see [24]). The adult form of the 0-2A
progenitor (known to be present in vivo [25]) may be a
more plausible candidate. In white matter, 0-2A cells
send out numerous extensive processes, some of which
appear to associate with nodes of Ranvier [15] - but, as
yet, little is known about their distribution or cellular
interactions in grey matter.
A second outstanding question is whether D-serine or
glycine is released in amounts sufficient to activate NMDA
receptors. As modulation of the glycine site on the recep-
tors would require the presence of an uptake mechanism at
the synapse (to keep glycine levels low), is glycine then
released along with D-serine? From the experiments of
Levi and Patrizio [11], exposure of type-2 astrocytes to
glutamate receptor agonists produces an increased release
of glycine that slightly exceeds the release of L-serine.
Thirdly, what is the role of the different types of glial glu-
tamate receptors in such processes? The presence of mul-
tiple types of non-NMDA glutamate receptors (including
the Ca2 +-permeable variety) in glia, and the absence of
NMDA receptors, suggests a complex picture. Finally, why
have a 'relay' mechanism of this sort to modify NMDA
receptor activation, unless the relay itself is subject to mod-
ification? The answer could lie in understanding more
about the factors which control the ability of glia to release
amino acids under normal and pathological conditions.
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